drugset / Trial / NCT04356664

Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis

NCT04356664

Phase 2/3 Recruiting 180 enrolled Hopital Foch
RandomizedParallel-groupOpen-labelTreatment

Summary

Women suffering from endometriosis and/or adenomyosis may also suffer from infertility. GnRH agonist injection could improve implantation and therefore increase the pregnancy rate in these patients. This study was designed to evaluate effects of the additional of GnRH agonist (single or 2 doses) to the routine oestrogens and progestins use as support before Frozen Embryon Transfer as compared to oestrogens and progestins only.

Timeline

Start
2021-03-18
Primary completion
2026-06-18
Completion
2026-06-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Decapeptyl Unknown 3 mg Intramuscular